ExcepGen is Drug Discovery in United Kingdom that focus on producer business. Founded in 2017. They cover business area such as producer, complex human protein, an innovative platform, drug discovery, proprietary technology, human cell, inactive, full-length form, high yield, no workaround, laboratory, their development time, their high-throughput screening, well pipeline decision.
2017
( 7 years old in 2024 )
Producer
-
F6s Accounting, Unit 6 Queens Yard
White Post Lane
London E9 5EN
England, United Kingdom
Private
producercomplex human proteinan innovative platformdrug discoveryproprietary technologyhuman cellinactive, full-length formhigh yieldno workaroundlaboratorytheir development timetheir high-throughput screeningwell pipeline decision
* We use standard office opening hours in near ExcepGen's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
ExcepGen is Drug Discovery business from United Kingdom that founded in 2017 (7 years old in 2024), ExcepGen business is focusing on Producer.
ExcepGen headquarter office and corporate office address is located in F6s Accounting, Unit 6 Queens Yard White Post Lane London E9 5EN England, United Kingdom.
ExcepGen was founded in United Kingdom.
In 2024, ExcepGen is currently focus on producer sector.
Above is snippet of Google Trends for "producer" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with ExcepGen, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
